Presentation to Outline Innovative Methodology for Developing Indication-Specific Outcome Measures in Rare Disease Clinical Trials The...
Le spécialiste des sciences cognitives Cogstate a annoncé aujourd’hui que sa division Soins de santé (Healthcare) a obtenu l’autorisation de...
Announcing LifeSpring Physiotherapy as Latest Customer The cognitive science company, Cogstate, today announced that its Healthcare...
Siemers will provide expert advice for Cogstate in neurodegeneration research The cognitive science company, Cogstate Ltd (ASX.CGS) today...
From the Interdisciplinary Conference on Orthopedic Value Based Care sponsored by the American College of Perioperative Medicine, Cogstate...
The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the addition of Dr. Chris Edgar, Senior Vice President, Clinical Science...
Cogstate to Support Rater Training and Certification Program to Enable Accelerated Study Start-up in Alzheimer’s Disease Clinical Trials...
The cognitive science company, Cogstate today announced the commercial deployment of its Cognigram™ digital cognitive assessment system at the...
Company to Launch COGNIGRAM™ Digital Cognitive Testing Tool in U.S. Healthcare Market The cognitive science company, Cogstate today...
Company to deliver novel solutions to ensure high-quality neuropsychological measures in clinical trials The cognitive science company...
Cognitive science company, Cogstate Ltd (ASX.CGS) and Clinical Ink, the leading provider of eSource and patient engagement technologies, today...
Cogstate Ltd (ASX:CGS), leaders in the measurement of cognition in clinical trials, is pleased to announce that their iPad-based...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads